Metformin in obesity associated with antipsychotic drug administration: a pilot study.
Baptista
T
T
Hernàndez
L
L
Prieto
L A
LA
Boyero
E C
EC
de Mendoza
S
S
D000328:Adult; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019540:Area Under Curve; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D010054:Brief Psychiatric Rating Scale / Q000706:statistics & numerical data; D002908:Chronic Disease; D005260:Female; D005951:Glucose Tolerance Test / Q000706:statistics & numerical data; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy*; D010865:Pilot Projects; D010919:Placebos; D012559:Schizophrenia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D015431:Weight Loss / Q000187:drug effects
D014150:Antipsychotic Agents; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D008687:Metformin